Style | Citing Format |
---|---|
MLA | Amani B, Amani B. "Comparison of Effectiveness and Safety of Nirmatrelvir/Ritonavir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis." Expert Review of Anti-Infective Therapy, vol. , no. , 2024, pp. -. |
APA | Amani B, Amani B (2024). Comparison of Effectiveness and Safety of Nirmatrelvir/Ritonavir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis. Expert Review of Anti-Infective Therapy, (), -. |
Chicago | Amani B, Amani B. "Comparison of Effectiveness and Safety of Nirmatrelvir/Ritonavir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis." Expert Review of Anti-Infective Therapy , no. (2024): -. |
Harvard | Amani B, Amani B (2024) 'Comparison of Effectiveness and Safety of Nirmatrelvir/Ritonavir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis', Expert Review of Anti-Infective Therapy, (), pp. -. |
Vancouver | Amani B, Amani B. Comparison of Effectiveness and Safety of Nirmatrelvir/Ritonavir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis. Expert Review of Anti-Infective Therapy. 2024;():-. |
BibTex | @article{ author = {Amani B and Amani B}, title = {Comparison of Effectiveness and Safety of Nirmatrelvir/Ritonavir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis}, journal = {Expert Review of Anti-Infective Therapy}, volume = {}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Amani B AU - Amani B TI - Comparison of Effectiveness and Safety of Nirmatrelvir/Ritonavir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis JO - Expert Review of Anti-Infective Therapy VL - IS - SP - EP - PY - 2024 ER - |